T existence of autoantibodies and immune (ii) both the synovial and extra-articular features of RA are the predictable outcome of activation of complexes in rheumatoid arthritis (RA) has been recognized for several decades. Antibodies to IgG, or macrophages bearing the receptor FccRIIIa by immune complexes of this type, with the producrheumatoid factors (RF ), were reported nearly 60 yr ago [1, 2] . A pathogenic role for immune complexes, tion of cytokines such as TNF-a, and resulting inflammation; and those formed by RF of the IgG class in particular, seemed likely in the 1970s, but has become less fashion-(iii) in synovium, TNF-a also induces changes in fibroblasts which facilitate the local accumulation able, being championed only by a few, notably Roitt, Mannik and Natvig [3] [4] [5] [6] . Interest in RF-based of ectopic lymphoid tissue and plasma cells, with the generation of high local levels of RF and the immune complexes waned for three reasons. Firstly, there is no obvious reason why these should specifically formation of larger immune complex aggregates which induce further inflammatory events, includproduce joint disease. Secondly, the relationship between RF and disease is not one to one. Thirdly, ing complement activation. the putative pathogenic effects of immune complexes
Perhaps the most important aspect of this hypothesis were considered chiefly in terms of complement is that it refocuses attention on the possibility that activation. By 1990, cytokines such as tumour necrosis permanent interruption of autoantibody production factor alpha ( TNF-a) had come to be considered the might effectively cure the disease. We propose that this more important mediators in the joint, and therapeutic might be possible. trials using cytokine blockade have reinforced that
Much of the hypothesis is based on conventional view [7] . [24] and, interestingly, a significant confirmed these findings in normal adult tissues, both in human and marmoset, and also found FccRIII+ proportion of Felty's syndrome patients have oligoclonal LGL expansions which may resemble leukaemia cells in normal pericardium and salivary gland [39] . In dermis, expression is minimal, with the important [25] . Activation of LGL in bone marrow may contribute to neutropenia, which may also be dependent on exception of the sites of mechanical stress where rheumatoid nodules form. At these sites, the majority of binding of complexes to the FccRIIIb receptor isoform on granulocytes, with a reduction in neutrophil life macrophages show FccRIIIa expression [13] . Other tissues show minimal FccRIIIa expression.
span.
Synovitis not only dominates the clinical picture in FccRIIIa expression by macrophages is induced by TGF-b in vitro [19] . Many cell types produce TGF-b RA, but differs from other connective tissue lesions in the formation of ectopic lymphoid tissue. This may be in response to mechanical stress [20] and induction of FccRIIIa by TGF-b would provide a convenient explained by another specialized feature of the synovial immunological microenvironment. Synovial fibroexplanation for the link between mechanical stress and both site and severity of inflammation in RA. The blasts, together with bone marrow fibroblasts, differ from fibroblasts from other tissues in that they respond detailed pattern of synovial and dermal lesions [21] suggests that mechanical stresses on soft tissue more readily to cytokines with the expression of molecules associated with B-lymphocyte survival and difstretched over bone in a confined space are particularly relevant: in metacarpophalangeal joints, in metatarsoferentiation [12, [26] [27] [28] . The expression of vascular cell adhesion molecule-1 ( VCAM-1) on subintimal phalangeal joints, where synovium is compressed between bone and ground, and over the olecranon.
fibroblasts in RA is likely to be crucial, and is consistent with an effect of TNF-a generated in response to The pattern of macrophage FccRIIIa expression is, therefore, a very reasonable map of pathological FccRIIIa ligation by immune complexes [12] . The expression in subintima of VCAM-1, together with changes in RA: synovitis, s.c. nodules at sites of stress, a prominent acute-phase response, suppressed haemcomplement decay-accelerating factor and complement receptor 2, allows the tissue to become colonized atopoiesis, lymphadenopathy, pericarditis and alveolitis [21] . The acute-phase response and anaemia of by B cells, with follicle centre formation and local differentiation into plasma cells. This superior ability RA are often thought to be secondary to the release of TNF-a and interleukin-6 (IL-6) from joints.
of synovial fibroblasts to support B-lymphocyte survival and differentiation has been confirmed in vitro. However, a direct interaction between immune complexes and FccRIIIa on Kupffer cells and macrophages A significant proportion of the B-cell clones in RA synovium are known to generate RF [3] . High local in bone marrow, with consequent cytokine-induced stimulation of hepatocytes and suppression of erythroconcentrations of IgG RF have been shown to allow the formation of larger complexes, which will not poiesis, would provide an equally good explanation.
The rheumatoid nodule may be seen as the hallmark only interact with Fc receptors, but will also fix complement [29] . connective tissue lesion of RA. The architecture of the nodule, with a ring of macrophages surrounding an
The above analysis (summarized in Fig. 1 ) can explain the targeting of joints in RA and the involvearea of necrosis, is consistent with a self-propagating response to a constant supply of extravascular immune ment of cytokines. Interest in RF finally waned in the 1980s because, despite many attempts, an RF assay complexes. Macrophages which, under the influence of mechanical stress, express FccRIIIa, will bind comwhich correlated precisely with clinical disease could not be developed. If pathogenicity of RF is dependent plexes and secrete TNF-a and reactive oxygen species. Ligation of FccRIIIa is also specifically implicated in not only on Ig isotype, but also on fine specificities which allow the formation of complexes of very specific release of the potent chemokine, monocyte chemoattractant protein 1 (MCP-1) [22] . These events will characteristics, then a poor correlation with total serum F. 1.-Local and systemic events in the pathogenesis of rheumatoid arthritis.
antibody levels should not be surprising. Inconsistent responses to IgG Fab peptides, which have been found to be elevated in RA (C. J. Elson, personal communicarelationships between antibody titres and clinical disease are familiar even in conditions in which the tion). It is also possible that the Fc binding peptides present in RF Fab regions mimic peptides in bacterial pathogenicity of autoantibodies is not in doubt. In the antiphospholipid syndrome, it has become clear that IgG binding proteins, such as staphylococcal protein A, to which T-cell responses are likely to exist. These pathogenic molecular interactions are dependent on complex steric considerations which may involve not responses are likely to be Class II restricted. A more central role for T cells in RA has been only antigen and antibody, but also other cofactors [30] . Moreover, in seronegative cases, RF may be fashionable in Europe for some time, despite the evidence that T cells in RA synovium are, if anything, sequestered within joints much of the time, with infrequent spill-over into the circulation.
hyporesponsive [32, 33] . T cells extracted from RA synovium may show a 'TH1' phenotype in vitro [34] , The mechanism proposed does not require that the immune complexes should be formed by IgG RF. Any but this does not alter the fact that B-cell survival and differentiation are occurring in the tissue, and that small complexes of similar characteristics might do. It is likely that features such as synovitis and pericarditis whatever T cells are present are providing the help required. in systemic lupus depend on other small complex species. Other small complex species may also be IgG RF may also promote survival of B cells of RF specificities in follicle centres by coating them with IgG responsible for some seronegative RA. However, complexes in which antibody is also antigen are particularly RF polymers associated with C3d. The detailed arguments involved are beyond the scope of this article, suited to the genesis of a syndrome in which synovitis is dominant. The fact that antibody is also antigen but it seems likely that B-cell clones which produce IgG RF can be self-perpetuating. There is also evidence means that optimal local conditions for complex formation will arise once synovium is colonized by from Natvig's group that the RF produced in rheumatoid joints do not derive from Ig genes used by B-cell clones generating IgG RF. These complexes may not only generate inflammation, but also contribute to 'physiological' IgM RF, but from unrelated Ig genes [6 ] . This is consistent with the idea that pathogenic local B lymphocyte survival by providing the positive signal conveyed by complexed antigen carrying the autoantibodies such as IgG RF develop by chance mutations within germinal centres during responses to complement component C3d.
The reasons for persistent production of RF in RA unrelated antigens [35] . This suggests that if B cells of pathogenic RF specificity are destroyed, the chance of are not clear. The association between RA and MHC Class II allotype suggests that T cells are involved [31] . them reappearing may be no greater than that of de novo appearance on the same genetic background. T-cell responses to Fc peptides are not present, but as Thompson et al. [5] argued, help may come from Selective destruction of B-cell clones of RF specificity poses major problems. Attempts to encourage these T cells recognizing foreign antigens endocytosed in the form of immune complexes by B cells of RF specificity.
clones to die using modified antigen (IgG) would have to compete with 50-100 g of native IgG. An alternative This mechanism could also be fuelled by T-cell clonal antibody to tumour necrosis factor alpha (cA2) 
